Signaling Pathways - MARK1 - Urokinases - Pyk2 - DPP-4
清除全部
- B3941 Talabostat mesylate2 CitationTarget: DPP-4Summary: DPP4抑制剂
- B2268 Amiloride HCl dihydrate中文名: 盐酸阿米洛利二水合物Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|UrokinasesSummary: 有效上皮钠通道(ENaC)阻断剂
- A8650 Saxagliptin中文名: 沙格列汀Target: DPP-4Summary: DPP4抑制剂
- A8345 PF-562271 HClTarget: FAK|Pyk2Summary: FAK/Pyk2抑制剂
- A8320 PF-00562271Target: FAK|Pyk2Summary: 有效的ATP竞争性FAK/Pyk2抑制剂
- A8310 PF-5622711 CitationTarget: FAK|Pyk2Summary: ATP竞争性的FAK抑制剂。
- A4445 4-Chlorophenylguanidine hydrochlorideTarget: UrokinasesSummary: 尿激酶(urokinase)抑制剂
- A3865 Teneligliptin hydrobromide中文名: 氢溴酸替格列汀Target: DPP-4Summary: DDP4抑制剂
- A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂
- A4038 Alogliptin (SYR-322)1 Citation中文名: 阿格列汀Target: DPP-4Summary: DPP-4抑制剂